Ketamine is classified as an “anesthetic agent.” It affects neuroplasticity (the brain’s ability to reorganize itself through forming neural connections) and excitotoxicity (the pathological process by which neurons are damaged by overactivation). It has been used in hospitals around the world for over 60 years. It is on the World Health Organization’s “List of Essential Medications;” the most effective and safe medicines needed in a health system. In recent years it has been found to have a profound effect on much mental health (Major Depressive Disorder, Anxiety, PTSD, OCD, Suicidal Ideation) and pain conditions (CRPS, Fibromyalgia, Migraines)
Chronic pain is a worldwide epidemic leading to the causes of disability. Chronic pain and depression often go hand in hand. Depression can cause pain and pain can cause depression. They create a vicious cycle in which pain worsens depression and depression worsens the experience of pain. Together they form a debilitating storm preventing individuals from enjoying life and at times performing even the most basic activities of daily living. The two conditions have considerable overlap. Ketamine is a major intersection in therapy for both. When administered in low dose, series infusions Ketamine has been shown to have rapid and profound effects in relieving depression (and some other mental health conditions) plus some transient improvement in pain perception. It is not a cure for either condition, rather a tool to help clients cope better and live life with their condition without such extremes in suffering. Often, “booster” infusions are needed after the series is complete to maintain the relief. The series will be tailor-made to each client by working closely with their ketamine provider.